Zymeworks (ZYME) Depreciation & Amortization (CF) (2022 - 2026)

Zymeworks' (ZYME) quarterly Depreciation & Amortization (CF) came in at $963000.0 in Q1 2026, down 1.83% year-on-year from $981000.0 in Q1 2025, and up 7.24% quarter-over-quarter from $898000.0 in Q4 2025.

Zymeworks (ZYME) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Zymeworks has disclosed Depreciation & Amortization (CF) across 5 years of filings, most recently posting $963000.0 for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $963000.0, down 1.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (down 11.12% YoY), and the FY2025 annual result was $3.7 million, down 12.39% from the prior year.
  • Depreciation & Amortization (CF) came in at $963000.0 for Q1 2026 at Zymeworks, up from $898000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.4 million in Q3 2023 to a low of $885000.0 in Q2 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $1.1 million (2024), against an average of $1.3 million.
  • Across the five-year window, Depreciation & Amortization (CF) soared 73.36% in 2023 and sank 56.89% in 2024, its largest moves.
  • Zymeworks' Depreciation & Amortization (CF) stood at $1.2 million in 2022, then surged by 33.33% to $1.5 million in 2023, then sank by 35.09% to $997000.0 in 2024, then dropped by 9.93% to $898000.0 in 2025, then increased by 7.24% to $963000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $963000.0 (Q1 2026), $898000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Zymeworks 1.73 Bn 1.36 Bn - 963,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 963,000.00
Mar 31, 2026 963,000.00
Dec 31, 2025 898,000.00
Dec 31, 2025 898,000.00
Sep 30, 2025 905,000.00
Sep 30, 2025 905,000.00
Jun 30, 2025 885,000.00
Jun 30, 2025 885,000.00
Mar 31, 2025 981,000.00
Mar 31, 2025 981,000.00
Dec 31, 2024 997,000.00
Dec 31, 2024 997,000.00
Sep 30, 2024 1.04 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.10 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 1.06 Mn
Mar 31, 2024 1.06 Mn
Dec 31, 2023 1.54 Mn
Dec 31, 2023 1.54 Mn